Last deal

$151.4M
Local Amount - CNY 1.1B

Amount

Series C

Stage

30.06.2023

Date

3

all rounds

$239.7M

Total amount

General

About Company
Worg Pharmaceuticals is developing new treatments for allergy and other diseases with high unmet medical needs and commercial potential.

Industry

Sector :

Subsector :

Keywords :

Also Known As

百明信康, 百明信康生物技术(杭州)有限公司

founded date

01.01.2018

Number of employees

Last funding type

Series C

IPO status

Private

Description

The company focuses on building a pipeline of therapeutical indications, with a commitment to accelerating the development of new treatments for allergies and other diseases. Worg Pharmaceuticals is dedicated to addressing significant medical needs by creating innovative solutions that have the potential to make a positive impact on patient health.